Showing 1 posts of 1 posts found.
Sanofi has said it will stop investment and research into creating new diabetes and cardiovascular drugs, as part of the …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO